Simplifying residual DNA analysis in viral vector production: focus on E1A

Cell & Gene Therapy Insights 2022; 8(7), 837–840

DOI: 10.18609/cgti.2022.129

Published: 12 August 2022
Innovator Insight


In this summury, Srinath Kashi Ranganath summarises how residual DNA analysis of the E1A fragment can be performed for therapeutic-grade AAV production.